Muramyl peptides in the complex treatment of cervical intraepithelial neoplasia associated with human papillomavirus
Research objective: the use of an immunomodulator III generation with a wide range of action (muramyl peptide drug Liastenum) to increase the effectiveness of treatment of cervical intraepithelial neoplasia grade I associated with human papilloma virus (HPV) and to reduce the recurrence of cervical...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Publishing House TRILIST,
2021-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|